Nutema Blood Bank Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.82 M
as on 03-01-2025
- Revenue 69.20%
(FY 2022)
- Profit 18.80%
(FY 2022)
- Ebitda 17.39%
(FY 2022)
- Net Worth 81.25%
(FY 2022)
- Total Assets 17.84%
(FY 2022)
About Nutema Blood Bank
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.82 M.
Sandeep Garg, Shweta Garg, and Anshuman Sharma serve as directors at the Company.
- CIN/LLPIN
U85100UP2019PTC116374
- Company No.
116374
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nutema Blood Bank?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Garg  | Director | 30-Apr-2019 | Current |
| Shweta Garg | Director | 30-Apr-2019 | Current |
| Anshuman Sharma | Director | 30-Apr-2019 | Current |
Financial Performance of Nutema Blood Bank.
Nutema Blood Bank Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 69.2% increase. The company also saw a substantial improvement in profitability, with a 18.8% increase in profit. The company's net worth Soared by an impressive increase of 81.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutema Blood Bank?
Unlock access to Nutema Blood Bank's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ketumanpharmacy Private LimitedActive 1 year 8 monthsSandeep Garg and Shweta Garg are mutual person
- Kalyani Pathological Solutions Private LimitedActive 8 years 10 months
Sandeep Garg and Shweta Garg are mutual person
- Ketumanhospital Private LimitedActive 1 year 11 months
Sandeep Garg and Shweta Garg are mutual person
Charges (Loans)
₹2.82 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2024 | Others | ₹2.82 M | Open |
How Many Employees Work at Nutema Blood Bank?
Unlock and access historical data on people associated with Nutema Blood Bank, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutema Blood Bank, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutema Blood Bank's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.